RxDoctor Payments Data

Cherie Morris, MD

Family Medicine · Kingman, KSNPI 1174550321

Payments from drug & device makers

$1,307in general payments, 2019–2025

Across 84 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$481
  • Amgen$314
  • Lilly USA, LLC$131
  • E.r. Squibb & Sons, L.L.C.$46
  • Electromed, Inc.$43
  • Insulet Corporation$38
  • plus $255 from 12 others

What the payments were for

  • Food & beverage$1,29499%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,307 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$309
Medicare patients
27
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban50$33,963
XareltoRivaroxaban63$23,757
TrulicityDulaglutide16$14,557
OzempicSemaglutide15$13,770
JardianceEmpagliflozin14$11,865
JanuviaSitagliptin Phosphate22$11,185
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog38$10,855
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,926
AbrysvoRsv Vacc, Pref A And Pref B/Pf21$6,681
MyrbetriqMirabegron24$5,538
ShingrixVaricella-Zoster Ge/As01b/Pf15$3,319
Arnuity ElliptaFluticasone Furoate13$3,096
Albuterol Sulfate HfaAlbuterol Sulfate108$2,909
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$2,080
Gabapentin139$1,846

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$14$40,64471 claims
Johnson & JohnsonXarelto$26$23,75763 claims
Lilly USA, LLCTrulicity$131$14,55716 claims
Novo NordiskOzempic$481$13,77015 claims
AstraZenecaBreztri Aerosphere$33$6,92611 claims
Astellas Pharma US IncMyrbetriq$32$5,53824 claims
AbbVieSynthroid$20$1,12133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Kingman

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →